Planned sale of 6,703 EMR shares under Rule 144 (NYSE: EMR)

Rhea-AI Filing Summary

A holder of common stock has filed a Rule 144 notice to sell 6,703 shares. The planned sale has an aggregate market value of $1,073,988.00 and involves common stock listed on the NYSE. The shares are to be sold through Charles Schwab Corp, with an approximate sale date of 02/09/2026.

The shares to be sold were acquired from the issuer as equity compensation, including restricted stock awards and other equity grants made between 11/06/2024 and 11/06/2025. The issuer has 562,000,000 shares outstanding, providing context for the size of this planned sale.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Sticj	Charles Schwab Corp 3000 Schwab Way Westlake TX 76262	6703	1073988.00	562000000	02/09/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/06/2024	Restricted Stock Award	Issuer			1087	11/06/2024	Equity Compensation
Common	11/03/2025	Equity Compensation	Issuer			3381	11/03/2025	Equity Compensation
Common	11/04/2025	Restricted Stock Award	Issuer			1145	11/04/2025	Equity Compensation
Common	11/06/2025	Restricted Stock Award	Issuer			1090	11/06/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many EMR common shares are planned for sale under this Form 144?

The notice covers a planned sale of 6,703 common shares. These shares are to be sold through Charles Schwab Corp on the NYSE, giving investors a sense of the transaction’s scale relative to the public market.

What is the aggregate market value of the EMR shares to be sold?

The planned sale has an aggregate market value of $1,073,988.00. This figure reflects the total market value of the 6,703 common shares covered by the notice at the time the filing details were prepared.

When is the approximate sale date for the EMR shares under Rule 144?

The approximate date of sale disclosed is 02/09/2026. This indicates when the selling holder expects to begin executing sales of the 6,703 common shares described in the Rule 144 notice on the NYSE.

How were the EMR shares being sold under this Form 144 originally acquired?

The shares were acquired from the issuer through equity compensation, including several restricted stock awards. Acquisition dates range from 11/06/2024 to 11/06/2025, reflecting multiple compensation-related grants rather than open-market purchases.

How many EMR shares are outstanding compared to the amount being sold?

The issuer has 562,000,000 common shares outstanding. The Rule 144 notice covers 6,703 shares, allowing investors to compare the planned sale size to the company’s total share count disclosed in the filing.

Which broker and exchange are involved in this EMR Rule 144 sale?

The shares are to be sold through Charles Schwab Corp, located at 3000 Schwab Way, Westlake, TX 76262. The common stock is listed on the NYSE, which is the named securities exchange for the planned Rule 144 transaction.